Join Us in November: NANOBIOTIX Takes the Stage at Exciting Investor Conferences!
Welcome to the Healthcare Innovation Conference Season! Nanobiotix Making Waves at Multiple Conferences PARIS and CAMBRIDGE, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company”), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that…